Spark sets $850,000 price for blindness gene therapy

Spark Therapeutics announced it will charge $850,000 per patient for its Luxturna breakthrough gene therapy treatment —- a lower price than analysts and investors had predicted.

Source: Pharma Manufacturing
More...